NO974270L - Insulinderivater - Google Patents
InsulinderivaterInfo
- Publication number
- NO974270L NO974270L NO974270A NO974270A NO974270L NO 974270 L NO974270 L NO 974270L NO 974270 A NO974270 A NO 974270A NO 974270 A NO974270 A NO 974270A NO 974270 L NO974270 L NO 974270L
- Authority
- NO
- Norway
- Prior art keywords
- insulin derivatives
- group
- chain
- amino acid
- terminal amino
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical class N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title abstract 2
- 125000001433 C-terminal amino-acid group Chemical group 0.000 abstract 1
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 230000005923 long-lasting effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK27695 | 1995-03-17 | ||
| PCT/DK1996/000107 WO1996029344A1 (en) | 1995-03-17 | 1996-03-18 | Insulin derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO974270D0 NO974270D0 (no) | 1997-09-16 |
| NO974270L true NO974270L (no) | 1997-11-14 |
Family
ID=8091725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO974270A NO974270L (no) | 1995-03-17 | 1997-09-16 | Insulinderivater |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0871665B1 (cs) |
| JP (1) | JP3872105B2 (cs) |
| KR (1) | KR19980703039A (cs) |
| CN (1) | CN1196061A (cs) |
| AT (1) | ATE245659T1 (cs) |
| AU (1) | AU720966B2 (cs) |
| BR (1) | BR9607647A (cs) |
| CA (1) | CA2215694A1 (cs) |
| CZ (1) | CZ289343B6 (cs) |
| DE (1) | DE69629210T2 (cs) |
| HU (1) | HUP9800523A3 (cs) |
| NO (1) | NO974270L (cs) |
| PL (1) | PL183698B1 (cs) |
| WO (1) | WO1996029344A1 (cs) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5693609A (en) * | 1994-11-17 | 1997-12-02 | Eli Lilly And Company | Acylated insulin analogs |
| US6451970B1 (en) | 1996-02-21 | 2002-09-17 | Novo Nordisk A/S | Peptide derivatives |
| US6458924B2 (en) | 1996-08-30 | 2002-10-01 | Novo Nordisk A/S | Derivatives of GLP-1 analogs |
| US6268343B1 (en) | 1996-08-30 | 2001-07-31 | Novo Nordisk A/S | Derivatives of GLP-1 analogs |
| US7235627B2 (en) | 1996-08-30 | 2007-06-26 | Novo Nordisk A/S | Derivatives of GLP-1 analogs |
| CA2306905A1 (en) * | 1997-10-24 | 1999-05-06 | Eli Lilly And Company | Fatty acid-acylated insulin analogs |
| CO4970787A1 (es) | 1997-12-23 | 2000-11-07 | Lilly Co Eli | Composiciones insolubles de insulina y derivados de insulina que controlan la glucosa sanguinea |
| CA2342967A1 (en) * | 1998-12-08 | 2000-06-15 | Biovation Limited | Modifying protein immunogenicity |
| TWI242000B (en) * | 1998-12-10 | 2005-10-21 | Univ Southern California | Reversible aqueous pH sensitive lipidizing reagents, compositions and methods of use |
| AU2003236201A1 (en) | 2002-05-07 | 2003-11-11 | Novo Nordisk A/S | Soluble formulations comprising monomeric insulin and acylated insulin |
| CN1247616C (zh) * | 2002-07-19 | 2006-03-29 | 上海中科生龙达生物技术（集团）有限公司 | 新的单体胰岛素，药物组合物及其制法 |
| AU2004261353B2 (en) | 2003-08-05 | 2009-12-10 | Novo Nordisk A/S | Novel insulin derivatives |
| EP1687428A1 (en) | 2003-11-14 | 2006-08-09 | Novo Nordisk A/S | Processes for making acylated insulin |
| MXPA06008209A (es) | 2004-01-21 | 2006-08-31 | Novo Nordisk As | Conjugacion de peptidos mediada por transglutaminasa. |
| EA012071B1 (ru) | 2004-03-17 | 2009-08-28 | 7ТиЭм ФАРМА А/С | Селективные агонисты рецептора y4 для терапевтического воздействия |
| WO2005089789A2 (en) | 2004-03-17 | 2005-09-29 | 7Tm Pharma A/S | Y2 selective receptor agonists for therapeutic interventions |
| JP4933455B2 (ja) | 2005-02-02 | 2012-05-16 | ノヴォ ノルディスク アー／エス | 新規のインスリン誘導体 |
| US20080171695A1 (en) | 2005-02-02 | 2008-07-17 | Novo Nordisk A/S | Insulin Derivatives |
| US20090074882A1 (en) | 2005-12-28 | 2009-03-19 | Novo Nordisk A/S | Insulin compositions and method of making a composition |
| ES2387955T3 (es) | 2006-02-27 | 2012-10-04 | Novo Nordisk A/S | Derivados de insulina |
| KR101441444B1 (ko) | 2006-05-09 | 2014-09-18 | 노보 노르디스크 에이/에스 | 인슐린 유도체 |
| WO2008015099A2 (en) | 2006-07-31 | 2008-02-07 | Novo Nordisk A/S | Pegylated, extended insulins |
| HUE029512T2 (en) | 2006-09-22 | 2017-03-28 | Novo Nordisk As | Protease Resistant Insulin Analogs |
| US9387176B2 (en) | 2007-04-30 | 2016-07-12 | Novo Nordisk A/S | Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein |
| ES2744384T3 (es) | 2007-06-13 | 2020-02-24 | Novo Nordisk As | Formulación farmacéutica que comprende un derivado de insulina |
| ES2543393T3 (es) | 2007-11-08 | 2015-08-18 | Novo Nordisk A/S | Derivado de insulina |
| EP2058330A1 (en) * | 2007-11-08 | 2009-05-13 | Novo Nordisk A/S | Insulin derivative |
| ES2618073T3 (es) | 2008-03-14 | 2017-06-20 | Novo Nordisk A/S | Análogos de insulina estabilizados frente a proteasas |
| KR20110004366A (ko) | 2008-03-18 | 2011-01-13 | 노보 노르디스크 에이/에스 | 프로테아제 안정화되고, 아실화된 인슐린 유사체 |
| CN102202683A (zh) | 2008-10-30 | 2011-09-28 | 诺沃-诺迪斯克有限公司 | 用少于每日一次的注射频率注射胰岛素来治疗糖尿病 |
| JP6049625B2 (ja) | 2010-10-27 | 2016-12-21 | ノヴォ ノルディスク アー／エス | 様々な注射間隔を用いて施されるインスリン注射を使用する、真性糖尿病の治療 |
| KR20150002777A (ko) | 2012-04-11 | 2015-01-07 | 노보 노르디스크 에이/에스 | 인슐린 제제 |
| US10137172B2 (en) | 2013-04-30 | 2018-11-27 | Novo Nordisk A/S | Administration regime |
| CN105636979B (zh) | 2013-10-07 | 2020-01-10 | 诺和诺德股份有限公司 | 胰岛素类似物的新衍生物 |
| AR099569A1 (es) | 2014-02-28 | 2016-08-03 | Novo Nordisk As | Derivados de insulina y los usos médicos de estos |
| SI3554534T1 (sl) | 2016-12-16 | 2021-09-30 | Novo Nordisk A/S | Farmacevtski sestavki, ki vsebujejo inzulin |
| MX2020001525A (es) | 2017-08-24 | 2020-03-20 | Novo Nordisk As | Composiciones de peptido similar al glucagon tipo 1 (glp-1) y sus usos. |
| US10335464B1 (en) | 2018-06-26 | 2019-07-02 | Novo Nordisk A/S | Device for titrating basal insulin |
| EP3894391A1 (en) | 2018-12-11 | 2021-10-20 | Sanofi | Peptide binder |
| JP7518149B2 (ja) | 2019-07-12 | 2024-07-17 | ノヴォ ノルディスク アー／エス | 高濃度インスリン製剤 |
| CN115135304A (zh) | 2020-02-18 | 2022-09-30 | 诺和诺德股份有限公司 | Glp-1组合物及其用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3844211A1 (de) * | 1988-12-29 | 1990-07-05 | Hoechst Ag | Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung |
| DK155690D0 (da) * | 1990-06-28 | 1990-06-28 | Novo Nordisk As | Nye peptider |
| SI0792290T1 (en) * | 1993-09-17 | 2001-12-31 | Novo Nordisk As | Acylated insulin |
-
1996
- 1996-03-18 BR BR9607647A patent/BR9607647A/pt not_active Application Discontinuation
- 1996-03-18 WO PCT/DK1996/000107 patent/WO1996029344A1/en not_active Application Discontinuation
- 1996-03-18 JP JP52799596A patent/JP3872105B2/ja not_active Expired - Fee Related
- 1996-03-18 HU HU9800523A patent/HUP9800523A3/hu unknown
- 1996-03-18 EP EP96905764A patent/EP0871665B1/en not_active Expired - Lifetime
- 1996-03-18 PL PL96322299A patent/PL183698B1/pl unknown
- 1996-03-18 CZ CZ19972899A patent/CZ289343B6/cs not_active IP Right Cessation
- 1996-03-18 DE DE69629210T patent/DE69629210T2/de not_active Expired - Lifetime
- 1996-03-18 KR KR1019970706447A patent/KR19980703039A/ko not_active Ceased
- 1996-03-18 CN CN96193362A patent/CN1196061A/zh active Pending
- 1996-03-18 AT AT96905764T patent/ATE245659T1/de not_active IP Right Cessation
- 1996-03-18 AU AU49396/96A patent/AU720966B2/en not_active Ceased
- 1996-03-18 CA CA002215694A patent/CA2215694A1/en not_active Abandoned
-
1997
- 1997-09-16 NO NO974270A patent/NO974270L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0871665B1 (en) | 2003-07-23 |
| JP3872105B2 (ja) | 2007-01-24 |
| NO974270D0 (no) | 1997-09-16 |
| MX9707056A (es) | 1997-11-29 |
| CZ289997A3 (cs) | 1998-01-14 |
| AU4939696A (en) | 1996-10-08 |
| CN1196061A (zh) | 1998-10-14 |
| WO1996029344A1 (en) | 1996-09-26 |
| JPH11502110A (ja) | 1999-02-23 |
| DE69629210T2 (de) | 2004-04-22 |
| PL322299A1 (en) | 1998-01-19 |
| HUP9800523A2 (hu) | 1998-06-29 |
| CA2215694A1 (en) | 1996-09-26 |
| DE69629210D1 (de) | 2003-08-28 |
| ATE245659T1 (de) | 2003-08-15 |
| AU720966B2 (en) | 2000-06-22 |
| EP0871665A1 (en) | 1998-10-21 |
| BR9607647A (pt) | 1999-04-06 |
| PL183698B1 (pl) | 2002-06-28 |
| HUP9800523A3 (en) | 1998-09-28 |
| KR19980703039A (ko) | 1998-09-05 |
| CZ289343B6 (cs) | 2002-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO974270L (no) | Insulinderivater | |
| NO974269L (no) | Lipofile peptidhormonderivater | |
| NO20061026L (no) | Nye insulinderivater | |
| ATE399177T1 (de) | Derivate therapeutischer peptide | |
| SE9604341D0 (sv) | Hepta-peptide oxytocin analogue | |
| ATE262037T1 (de) | Modifizierte liganden für den tie-2-rezeptor | |
| NO974514L (no) | Syntetisk HPV6/11 hybrid L1 DNA som koder for humant papillomavirus Type 11 L1-protein | |
| ATE245435T1 (de) | Totalsynthese des amino hip analogen von didemnin a | |
| BR9609393A (pt) | Composição injetável de colágeno; segmentos de fibra de colágeno reconstituìdos. | |
| BR9713404A (pt) | ésteres de n-(aril/heteroarilacetil) aminoácidos, composições farmacêuticas compreendendo os mesmos, e métodos para a inibição da liberação de peptìdeo beta-amilóide e/ou de sua sìntese por uso de tais compostos. | |
| ES2102052T3 (es) | Preparaciones medicas que contienen undecapeptidos ciclicos n-metilados. | |
| ATE77628T1 (de) | Peptidverbindungen. | |
| FR2703054B1 (fr) | Promoteur vegetal inductible au stress et cellules vegetales contenant une unite d'expression d'une proteine d'interet comprenant ledit promoteur. | |
| DE68923572D1 (de) | Peptide. | |
| DE69834929D1 (de) | Verwendung eines organspezifischen ernährungmittels | |
| DE69518246D1 (de) | Aminosäuren konjugaten | |
| MX9206732A (es) | Nuevas proteinas inhibidoras de trombina a partir de sanguijuelas de tierra. | |
| DK0579785T3 (da) | Substituerede benzhydrylaminer som tlslutningsmolekyler til fastfasepeptidsyntese | |
| IT1277391B1 (it) | Peptidi ciclici analoghi della somatostatina ad attivita' inibitrice dell'ormone della crescita | |
| WO1998050423A3 (fr) | Analogues peptidiques et leurs utilisations notamment dans des compositions pharmaceutiques et pour le diagnostic | |
| SI1401871T1 (cs) | ||
| MX9802268A (es) | Nuevos derivados de la substancia pf1022 de ciclodepsipeptido. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |